In particular, TP53 mutation connects with raised expression of genes involved in mevalonate pathway in human breast cancer, and most importantly, mutant TP53 upregulates these genes and activates the mevalonate pathway, which is indispensable to keep the malignant status of breast cancer (178). This evidence concerns the gene TP53 and breast cancer.